21 August 2018 Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the upfront workflow of Agena’s MassARRAY®system. The... Read more
Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma PD-L1 IHC 22C3 pharmDx Now Approved to Identify Certain Urothelial Carcinoma Patients for Treatment With KEYTRUDA(R) (pembrolizumab) SANTA CLARA, Calif., August 21, 2018 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration (FDA) has approved its Dako PD-L1 IHC 22C3... Read more
Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma PD-L1 IHC 22C3 pharmDx Can Now Be Used as an Aid to Identify Urothelial Carcinoma Patients for Treatment With KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., August 8, 2018 Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for an... Read more
Download as PDF AUGUST 08, 2018 MINNEAPOLIS, Aug. 8, 2018 /PRNewswire/ — Bio-Techne has introduced a new range of Tocris Bioscience-branded stem cell research compounds produced to cGMP standards, which are suitable for use as ancillary materials in the development of stem cell therapies. Bio-Techne has a highly-qualified team who have full control over the... Read more
ITHACA, N.Y., August 1, 2018 — Advion, Inc., a leading systems and consumables provider for the life sciences industry, is pleased to announce the new location of the company headquarters within the Cornell Business and Technology Park at 61 Brown Rd., Suite 100, Ithaca, NY 14850. Sparked by growth in demand and the need for additional... Read more
ISNES, Belgium, Aug. 1, 2018 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced that its first product the “Total Nu.Q™ Assay” research use only (RUO) kit, is ready and available for purchase through Active Motif, its Global Sales and Distribution Partner (https://www.activemotif.com/catalog/1266/NuQ-total-assay). This kit, based on Volition’s proprietary Nucleosomics® technology, is the first in a range of... Read more
BREA, CALIF. — (Aug. 1, 2018) — Beckman Coulter announced today commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing for microbiology laboratories. The DxM MicroScan WalkAway system uses direct minimum inhibitory concentrations (MIC) for detection of antimicrobial resistance, offering greater confidence in results through gold-standard accuracy and the... Read more
Hilden, Germany, and Tokyo, Japan, August 1, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to prepare for introduction of new companion diagnostics simultaneous with new drug approvals. The non-exclusive master collaboration agreement for clinical laboratory research services... Read more
Hilden, Germany, and Germantown, Maryland, August 1, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its careHPV™ Test, one of the only molecular diagnostics for high-risk human papillomavirus (HPV) designed to screen women in low-resource settings, has been added to the World Health Organization (WHO) list of prequalified in vitro diagnostics... Read more
Thermo Fisher Scientific Showcases Innovations for Research and Clinical Labs at AACC 2018 CHICAGO, July 31, 2018 /PRNewswire/ — AACC — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest innovations for clinical and translational research during the 2018 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo (booth 3831), being... Read more